Английская Википедия:HP-505

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

HP-505 is a triple reuptake inhibitor that was investigated by Hoechst-Roussel Pharmaceuticals.[1] In mice, HP-505 was a potent inhibitor of tetrabenazine-induced ptosis which may indicate antidepressant activity.[2]

Pharmacology

HP-505 IC50 (µM)[1]
5-HT NE DA NE:5-HT DA:5-HT
0.19 ± 0.04 0.34 ± 0.1 0.66 ± 0.15 1.8 3.5

The inhibitory effect of HP-505 on serotonin reuptake is approximately 1.8 and 3.5 times stronger than on norepinephrine and dopamine, respectively.[1] Subsequent investigations have found that HP-505 acts on presynaptic dopamine transporters and is devoid of anticholinergic effects.[3]

Synthesis

The N-methylated analog is called HP-365 [59142-29-9].

An older synthesis is available, although more modern methods exist now:[4]

Файл:HP-365 synthesis.svg
HP-365 patent:[5]

References

Шаблон:Reflist


Шаблон:Nervous-system-drug-stub